1 State Pharmacopoeia Committee of the People's Republic of China, Pharmacopoeia of the People's Republic of China (Ⅱ), Chemical Industry Press, Beijing (2000). 2 The British Pharmacopoeia Commission, British Pharmacopoeia , HMSO, London (1993). 3 Weda, M., Zanen, P., de Boer, A.H., “Equivalence testing of salbutamol dry powder inhalers:In vitro impaction results versus in vivo efficacy”, International Journal of Pharmaceutics, 249 (1), 247-255 (2002). 4 Ashurst, I.C., “Metered dose inhaler for albuterol”, U.S.Pat., 6131566 (2000). 5 Reverchon, E., Della Porta, G., Pallado, P., “Supercritical antisolvent precipitation of salbutamol microparticles”, Powder Technology, 114, 17-22 (2001). 6 Ganderton, D., “The generation of respirable cloud from coarse powder aggregates”, Biopharm. Sci., 3, 101-105 (1992). 7 Esther, B., Nicholas, I.C., Robert, S.T., “A short synthesis of albuterol”, Synthesis, 2 (13), 960-966 (1988). 8 Chen, F.E., Yu, H.X., Wan, J.L., “Studies on synthesis of salbutamol sulfate I”, Chinese Journal of Medicinal Chemistry, 5 (3), 215-217 (1993). 9 He, W., Qin, H., Luo, X.D., “Improved method of synthesis albuterol ”, Huaxi Journal of Medicinal, 13 (4), 251-252 (1998). 10 Zeng, X.M., Martin, G.P., Marriott, C., Particle Interactions in Dry Powder Formulations for Inhalation, Taylor & Francis, London, 90-91 (2001). 11 Zeng, X.M., Martin, G.P., Marriott, C., Pritchard, J., “The influence of carrier morphology on drug delivery by dry powder inhalers”, Int. J. Pharm., 200 (1), 93-106 (2000). 12 Hinds, W.C., Aerosol Technology, Wiley, New York (1982). 13 Zhang, X.G., “Effect of lactose on physical-mixed powder subside in breathing tract”, Chinese J. Pharm., 32 (8), 354-356 (2001). 14 Hino, T., Serigano, T., Yamamoto, H., “Particle design of wogon extract dry powder for inhalation aerosols with granulation method”, International Journal of Pharmaceutics, 168 (1), 59-68 (1998). 15 Zeng, X.M., Martin, G.P., Tee, S.K., “Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder inhalers”, Adv. Drug Delivery Rev., 182 (2), 133-144 (1999). 16 Hassan, L., Martin, G.P., Marriott, C., Prime, D., “The influence of carrier and drug morphology on drug delivery from dry powder formulations”, Int. J. Pharm., 257, 283-296 (2003). 17 Violanto, M.R., Fishcher, H.W., “Method for making uniformly sized particles form water-insoluble organic compounds”, U.S.Pat., 4826689 (1989). 18 Zhang, K.C., Zhang, L.H., Crystal Growth, Science Press, Beijing (1981). 19 Chen, J.F., High Gravity Technology and Its Application, Chemical Industry Press, Beijing (2003). 20 Zhu, W.C., Wang, Y.H., Chen, J.F., “Synthesis of ultra-fine needle-like calcium carbonate particles by high-gravity reactive precipitation”, J. Chem. Eng. Chinese Univ., 16 (5), 560-564 (2002). |